SPHRY fundamentals
An in-depth look to Starpharma Holdings Ltd. operating, investing, and financing activities
SPHRY free cash flow for H1 24 is 1.36 M USD. For 2023, SPHRY free cash flow was -9.52 M USD and operating cash flow was -9.1 M USD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
TTM